RBGLY DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action – RBGLY
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”)
RBGLY DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action – RBGLY
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”)
DDD DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages 3D Systems Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 12 Deadline in Securities Class Action – DDD
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems
PEPG FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important August 8 Deadline in Securities Class Action – PEPG
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc.
RCKT IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals,
RCKT IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals,